NEW YORK (GenomeWeb News) - Fluidigm today filed a preliminary prospectus with the US Securities and Exchange Commission for a proposed initial public offering.

The filing revives the company's plans for an IPO after withdrawing an initial registration in 2008. At the time, the company hoped to raise up to $85 million, but abandoned the plan in September of that year amid the unfolding economic crisis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Differences in DNA methylation could be used to distinguish between DNA samples obtained from identical twins, researchers say.

A retrovirus that's been integrated into the human genome appears to have a role in embryonic development, researchers report.

A report from MIT identifies areas of scientific research where declining research support is hindering needed advances.

In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.